Browning hopes to include a clinical trial for the drug in patients considered at high risk of colorectal cancer, such as those with chronic intestinal inflammation like colitis, multiple previous polyps, or a strong family history of the disease. Dr. Darren D. Browning, one of the researchers at Augusta University, thinks that daily doses of Fildena decrease the formation of polyps and asymptomat